Success Metrics

Clinical Success Rate
80.0%

Based on 32 completed trials

Completion Rate
80%(32/40)
Active Trials
138(64%)
Results Posted
6%(2 trials)
Terminated
8(4%)

Phase Distribution

Ph not_applicable
101
47%
Ph phase_3
4
2%
Ph phase_2
30
14%
Ph phase_4
4
2%
Ph early_phase_1
5
2%
Ph phase_1
10
5%

Phase Distribution

15

Early Stage

30

Mid Stage

8

Late Stage

Phase Distribution154 total trials
Early Phase 1First-in-human
5(3.2%)
Phase 1Safety & dosage
10(6.5%)
Phase 2Efficacy & side effects
30(19.5%)
Phase 3Large-scale testing
4(2.6%)
Phase 4Post-market surveillance
4(2.6%)
N/ANon-phased studies
101(65.6%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

71.1%

32 of 45 finished

Non-Completion Rate

28.9%

13 ended early

Currently Active

138

trials recruiting

Total Trials

217

all time

Status Distribution
Active(163)
Completed(32)
Terminated(13)
Other(9)

Detailed Status

Recruiting113
Completed32
Active, not recruiting25
Not yet recruiting20
Terminated8
Withdrawn5

Development Timeline

Analytics

Development Status

Total Trials
217
Active
138
Success Rate
80.0%
Most Advanced
Phase 4

Trials by Phase

Early Phase 15 (3.2%)
Phase 110 (6.5%)
Phase 230 (19.5%)
Phase 34 (2.6%)
Phase 44 (2.6%)
N/A101 (65.6%)

Trials by Status

withdrawn52%
terminated84%
enrolling_by_invitation52%
not_yet_recruiting209%
active_not_recruiting2512%
recruiting11352%
suspended52%
completed3215%
unknown42%

Recent Activity

Clinical Trials (217)

Showing 20 of 217 trialsScroll for more
NCT07856394Not Applicable

Adding Spatially Fractionated Radiation Therapy to Standard Palliative Radiation for Improving Disease-Related Symptoms in Patients With Unresectable Solid Tumors

Recruiting
NCT07059884Not Applicable

Distance-Based Exercise to Preserve Function and Prevent Disability

Recruiting
NCT06630104Not Applicable

Understanding the Mechanisms of Clonal and Non-clonal Cytopenia Following CAR-T Therapy for Multiple Myeloma or CD19+ Lymphoproliferative Disorder (LPD)

Recruiting
NCT06498661Not Applicable

Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S01)

Active Not Recruiting
NCT07737314Not Applicable

Tele-HOPE: A Telehealth Pharmacist Opioid Patient Education Pilot Study

Not Yet Recruiting
NCT07685717Phase 2

Pirtobrutinib for the Treatment of Elderly Patients With Chronic Lymphocytic Leukemia

Recruiting
NCT06396598Not Applicable

Electronic Symptom Monitoring Program for Triggered Palliative Referrals in Patients With Thoracic Cancer

Completed
NCT07377006Not Applicable

Decision Support Tool to Enhance Germline Genetic Testing for Patients With Prostate Cancer

Recruiting
NCT07282444Not Applicable

A New Way to Share Radiation Therapy Plans Between Doctors, CORRECT Trial

Not Yet Recruiting
NCT07838974Phase 1

Adding Anakinra and Tocilizumab to Nivolumab and Ipilimumab for the Treatment of Melanoma Patients 50 Years of Age or Older

Not Yet Recruiting
NCT07835841Not Applicable

Blessing Stem Cells to Improve Spiritual Well Being and Quality of Life for Patients Undergoing Hematopoietic Stem Cell Transplantation

Not Yet Recruiting
NCT05035706Early Phase 1

Anti-Leukemia Immune Responses After Irradiation of Extramedullary Tumors

Active Not Recruiting
NCT07176000Not Applicable

Tailored Patient Navigation to Improve the Uptake of Lung Cancer Screening in Tribal Communities in Western Washington State, SACRED LUNGS Trial

Recruiting
NCT04090398Phase 2

Testing the Addition of Radium Therapy (Radium-223 Dichloride) to the Usual Chemotherapy Treatment (Paclitaxel) for Advanced Breast Cancer That Has Spread to the Bones

Active Not Recruiting
NCT07490860Not Applicable

A Restorative Justice-Based Lung Cancer Screening Decision-Making Support Intervention Tailored for Black Individuals to Increase Lung Cancer Screening Among Black Community Members, RESTORE Trial

Recruiting
NCT07094750Not Applicable

Randomization for the Identification of Best Treatment Intensity for Less Fit Adults With Acute Myeloid Leukemia and Myeloid Neoplasms

Recruiting
NCT05996627Phase 2

Belumosudil for the Pre-emptive Treatment of Patients With Chronic Graft Versus Host Disease

Recruiting
NCT07390968Phase 2

Self-Amplifying mRNA COVID-19 Vaccine (LUNAR-COV19) Versus Comirnaty Vaccine in Adult Hematopoietic Cell Transplant Patients

Not Yet Recruiting
NCT05081024

Establishing a ctDNA Biomarker to Improve Organ Preserving Strategies in Patients With Rectal Cancer

Recruiting
NCT06943664Phase 2

Photoimmunotherapy With ASP-1929 and Cemiplimab for the Treatment of Refractory, Inoperable, and Metastatic Stage IIIB-IV Non-small Cell Lung Cancer

Withdrawn

Drug Details

Intervention Type
OTHER
Total Trials
217